Scimplify, an Indian startup that helps pharmaceutical and agriculture corporations entry a spread of specialty chemical compounds, has raised $40 million in a brand new funding spherical co-led by Accel and Bertelsmann Investments to widen its footprint within the U.S. and attain new markets.
The Sequence B spherical pegs Scimplify’s valuation at about $150 million post-money, the corporate stated.
Specialty chemical compounds are very important for manufacturing in lots of industries, however entry remains to be an issue, as producers of those chemical compounds are scattered internationally. Firms have principally relied on Chinese language suppliers to supply such chemical compounds, however geopolitical tensions are more and more pushing producers to search for alternate options in different areas. Furthermore, clients usually discover it onerous to discover a particular chemical if they’re searching for a selected reactor, chemistry, or compliance corresponding to U.S. FDA or GMP.
Scimplify goals to attach producers with specialty chemical makers utilizing its platform, ATOMS, which lists specialty chemical compounds from over 5,000 factories run by over 200 producers throughout 10 international locations together with India, China, Vietnam, Egypt, and Japan. The startup primarily targets prescription drugs, agriculture, and business.
The startup vets producers, will get them audited by third-parties semi-annually, and segregates them primarily based on their geography, chemistry, capability, and compliance. It additionally process-engineers present chemical compounds to make them cost-effective and related for various use circumstances.
Scimplify has to date served 600 clients throughout greater than 16 international locations worldwide, co-founder Sachin Santhosh informed TechCrunch.
Not like different marketplaces, Santhosh stated, Simplify additionally presents made-to-order chemical compounds by working with chemical producers, and lets clients simply change from one recipe to a different utilizing its producer community.
Earlier than Scimplify, Santhosh labored on the B2B startups Bizongo and OffBusiness, each of which helped streamline procurement and provide chain processes for companies. His co-founders, Salil Srivastava and Dheeraj Dhingra, each beforehand labored at manufacturing provide chain firm Zetwerk.
The startup plans to make use of the contemporary money to scale its presence geographically, cater to new business segments, and improve R&D. Scimplify has subsidiaries in Dubai and Indonesia, and is trying to arrange workplaces within the U.S. and Japan. It has a staff of 150 individuals.
It’s now contemplating buying one or two chemical factories to unlock new varieties of shoppers and controlled markets, Santhosh informed TechCrunch.
The Sequence B additionally noticed participation from UMI and present buyers, Omnivore and 3one4 Capital. The corporate has raised funding of $54 million to date since its inception in 2023.
